Trials / Unknown
UnknownNCT01861080
Korean Registry of Target Organ Damages in Hypertension
Observational Study of Clinical Characteristics and Prognostic Factors of Korean Hypertensives
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,000 (estimated)
- Sponsor
- Dongtan Sacred Heart Hospital · Academic / Other
- Sex
- All
- Age
- 30 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to know prevalence of clinical or subclinical target organ damages in Korea hypertensives by constructing nationwide hypertension registry. We will register 5000 consecutive patients with incident hypertension at 20 major university hospitals in South Korea. We will investigate clinical/subclinical target organ damages, renin/aldosterone level and cardiovascular events in each patient.
Detailed description
Background: the exact prevalence of target organ damages in Korean hypertensives are unknown. Study Objective: to investigate the prevalence of target organ damages in Korean patients with incident hypertension. Study Design: prospective, multi-center and observational study Study Populaton: approximately 5000 consecutive patients with incident hypertension, who visited outpatients clinics and agreed to participate in the registry Primary outcome * Subclinical organ damages 1. left ventricular hypertrophy on electrocardiogram or echocardiography 2. increased intima media thickness of carotid artery (\> 0.9 mm) or plaque 3. increased pulse wave velocity (\> 12 m/s) 4. low estimated glomerular filtration rate (\< 60 ml/min/1.73 m2) or creatinine clearance (\<60 ml/min) * Established CV or renal disease 1. cerebrovascular disease: ischemic stroke; cerebral stroke; transient ischemic attack 2. Heart disease: myocardial infarction; angina; coronary revascularization; heart failure 3. Renal disease: diabetic retinopathy; serum creatinine M \> 133, W \> 124 mmol/L; proteinuria \> 300 mg/24 hr 4. Peripheral artery disease 5. Advanced retinopathy: hemorrhage or exudates, papilledema
Conditions
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2021-12-31
- Completion
- 2021-12-31
- First posted
- 2013-05-23
- Last updated
- 2019-02-08
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01861080. Inclusion in this directory is not an endorsement.